Study identifies new class of anticancer compounds for possible targeted therapy in blood cancers

A research team from the Department of Pharmacology and Therapeutics at Roswell Park Cancer Institute (RPCI) has discovered a new class of small-molecule compounds that are good candidates for… Source link